Biotechnology atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression – ATAI Life Sciences (NASDAQ:ATAI) Read more
Biotechnology FDA Approves Novartis’ Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine Tumors – Novartis (NYSE:NVS) Read more
Biotechnology Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025 – Eli Lilly and Co (NYSE:LLY) Read more
Biotechnology AstraZeneca’s Imfinzi/Chemo Combo Doubles Overall Survival In Biliary Tract Cancer Patients At 3 Years, Data Shows – AstraZeneca (NASDAQ:AZN) Read more
Biotechnology Roche’s Lymphoma Drug With Chemo Extends Survival In Pretreated Patients – Roche Holding (OTC:RHHBY) Read more
Biotechnology Pfizer Seeks Expanded Use Of Abrysvo As Vaccine Shows Potential In 18+ Patients – Pfizer (NYSE:PFE) Read more
Biotechnology Bristol Myers Squibb’s Acquired Adagrasib Combo Therapy May Benefit Colorectal Cancer Patients With Certain Mutation – Bristol-Myers Squibb (NYSE:BMY) Read more
Biotechnology AstraZeneca/Daiichi’s Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor – AstraZeneca (NASDAQ:AZN) Read more
Biotechnology FDA Approves Bristol-Myers/2seventy Bio’s Abecma For Earlier Use In Pretreated Blood Cancer Patients With Updated Boxed Warning On Secondary Cancer – 2seventy bio (NASDAQ:TSVT), Bristol-Myers Squibb (NYSE:BMY) Read more